Peter M. van de Ven
Papers
2
Total Citations
106
H-Index
2
About
Peter M. van de Ven is a leading researcher in the field of urologic oncology, with a specific focus on improving the preoperative prediction of pelvic lymph-node metastases in prostate cancer. His major contributions center on the integration of advanced imaging modalities—particularly prostate-specific membrane antigen (PSMA) positron emission tomography (PET) and magnetic resonance imaging (MRI)—into traditional clinical nomograms. In a landmark 2021 international multicenter study (71 citations), van de Ven and colleagues externally validated and enhanced the most frequently used nomograms by adding PSMA PET data, significantly improving their accuracy for predicting lymph-node involvement. Building on this, his 2023 work (35 citations) led to the development and external validation of a novel, intuitive nomogram that combines MRI and PSMA PET imaging, offering clinicians a more precise, non-invasive tool to identify patients who truly require extended pelvic lymph-node dissection. These achievements have direct clinical impact, helping to reduce unnecessary surgeries and their associated morbidities. Van de Ven’s research exemplifies the power of integrating molecular imaging with traditional risk assessment, setting a new standard for personalized prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2